Doximity, Inc. (DOCS) vs GRAIL Inc. (GRAL)

A side-by-side comparison of Doximity, Inc. and GRAIL Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Doximity, Inc. logo
DOCS
Doximity, Inc.
$5.20B
$27.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
GRAIL Inc. logo
GRAL
GRAIL Inc.
$5.89B
$137.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — DOCS vs GRAL

growth of $100 · dividends reinvested · last 2y
DOCS -5.8% (-2.9%/yr)GRAL +1028.0% (+235.9%/yr)GRAL compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020252026$94$1,128
DOCS GRAL

DOCS vs GRAL: by the numbers

  • •GRAL is the larger company ($5.89B vs $5.20B market cap).
  • •DOCS is profitable (25.48% net margin) while GRAL runs a net loss (-236.95%).

Metrics side by side

Valuation

MetricDOCSGRAL
P/E ratio32.69N/A
Forward P/E20.63N/A
PEG ratio0.63N/A
P/S ratio7.9335.65
P/B ratio5.672.32
EV / EBITDA23.31N/A
FCF yield5.76%N/A

Profitability

MetricDOCSGRAL
Gross margin88.07%-42.52%
Operating margin29.60%-362.95%
Net margin25.48%-236.95%
ROE18.24%-15.40%
ROIC15.35%-20.26%

Growth (annualized)

MetricDOCSGRAL
Revenue CAGR (5Y)21.94%N/A
EPS CAGR (5Y)54.32%N/A
FCF CAGR (5Y)23.75%N/A
Total return CAGR (5Y)-20.25%N/A

Frequently asked

Is DOCS or GRAL more profitable?
DOCS runs the higher net margin — DOCS at 25.48% versus GRAL at -236.95%.

Go deeper

Full DOCS analysisFull GRAL analysisInteractive comparison tool

Dig into the metrics

Doximity P/E ratioDoximity ROEGRAIL ROEDoximity operating marginGRAIL operating marginDoximity revenue growthGRAIL revenue growthDoximity free cash flowGRAIL free cash flow

Doximity & GRAIL appear in these rankings

Fastest Revenue Growth StocksHighest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.